Results 21 to 30 of about 2,311,673 (316)

Neurologic Manifestations of the Antiphospholipid Syndrome — an Update

open access: yesCurrent Neurology and Neuroscience Reports, 2021
In recent years, the spectrum of neurological manifestations of antiphospholipid syndrome (APS) has been growing. We provide a critical review of the literature with special emphasis on presentation, proposed mechanisms of disease, and treatment of ...
Miguel Leal Rato   +3 more
semanticscholar   +1 more source

Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report

open access: yesJournal of Cardiothoracic Surgery, 2021
Background Antiphospholipid syndrome is an antibody mediated pro-thrombotic state leading to various arterial and venous thromboses. The syndrome can be either primary or secondary to other autoimmune diseases, commonly systemic lupus erythematosus ...
Yan Le Ho   +3 more
doaj   +1 more source

Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial

open access: yesBlood Advances, 2021
Key Points The primary outcome, stroke, occurred in 6 of 23 patients randomized to apixaban compared with 0 of 25 patients randomized to warfarin. This study with limitations suggests that apixaban is not an equitable substitute for warfarin to prevent ...
S. Woller   +11 more
semanticscholar   +1 more source

Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome

open access: yesTomography, 2022
Stroke in young patients requires thorough evaluation as they often lack risk factors. Antiphospholipid syndrome can cause arterial thrombosis and pregnancy loss; hence, differential diagnoses should include seronegative antiphospholipid syndrome.
Hee Sue Kim   +3 more
doaj   +1 more source

Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis [PDF]

open access: yes, 2002
A significant proportion of patients with Essential Thrombocythaemia (ET) have thrombotic complications which have an important impact upon the quality, and duration of their life.
Carr, P.   +5 more
core   +1 more source

Antiphospholipid Syndrome

open access: yesJournal of Investigative Dermatology, 1993
The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antibodies, are a family of autoantibodies directed predominantly against negatively charged phospholipids. Many studies have confirmed that patients with these antibodies are prone to repeated episodes of thrombosis, fetal losses, and thrombocytopenia.
Asherson, Ronald A., Cervera, Ricard
openaire   +2 more sources

RETROSPECTIVE ANALYSIS OF MEDICAL CHARTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

open access: yesМедична наука України, 2023
Background. Antiphospholipid attracts the attention of clinicians in various fields of medicine. This pathology is characterized by a triad of clinical and laboratory signs: recurrent venous or arterial thrombosis with localization in any part of the ...
V. I. Savytskyi
doaj   +1 more source

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 [PDF]

open access: yes, 2020
Background and purpose Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported.
Boon, Paul   +6 more
core   +2 more sources

Catastrophic antiphospholipid syndrome presenting as fever of unknown origin

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2012
Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss.
Fatma I Al-Beladi
doaj   +1 more source

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice [PDF]

open access: yes, 2011
Background: We have empirically noted that many physicians routinely request anti-phospholipid antibodies (aPL) without a correct clinical indication. The aim of this study was to evaluate retrospectively whether aPL testing at our Thrombosis Centre was ...
Barcellona D   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy